Amir H. Lebastchi

Title(s)Assistant Professor of Clinical Urology
SchoolKeck School of Medicine of Usc
Address1441 Eastlake Avenue
Health Sciences Campus
Los Angeles CA 90033
vCardDownload vCard

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Identifying the best candidate for focal therapy: a comprehensive review. Prostate Cancer Prostatic Dis. 2024 Oct 23. Ghoreifi A, Gomella L, Hu JC, Konety B, Lunelli L, Rastinehad AR, Salomon G, Taneja S, Tourinho-Barbosa R, Lebastchi AH. PMID: 39443815.
      View in: PubMed   Mentions:    Fields:    
    2. Salvage High-Intensity Focused Ultrasound for Prostate Cancer after Radiation Failure: A Narrative Review. Curr Oncol. 2024 Jun 26; 31(7):3669-3681. Sobhani S, Dadabhoy A, Ghoreifi A, Lebastchi AH. PMID: 39057142; PMCID: PMC11276396.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    3. Timing, incidence and management of delayed bleeding after partial nephrectomy in patients at risk for recurrent, bilateral, multifocal renal tumors. Urol Oncol. 2024 Jul; 42(7):222.e1-222.e7. Gomella PT, Solomon J, Ahdoot M, Gurram S, Lebastchi AH, Levy E, Krishnasamy V, Kassin MT, Chang R, Wood BJ, Linehan WM, Ball MW. PMID: 38614921.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    4. Transperineal vs transrectal magnetic resonance and ultrasound image fusion prostate biopsy: a pair-matched comparison. Sci Rep. 2023 08 18; 13(1):13457. Kaneko M, Medina LG, Lenon MSL, Hemal S, Sayegh AS, Jadvar DS, Ramacciotti LS, Paralkar D, Cacciamani GE, Lebastchi AH, Salhia B, Aron M, Hopstone M, Duddalwar V, Palmer SL, Gill IS, Abreu AL. PMID: 37596374; PMCID: PMC10439224.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    5. Primary Whole-gland Ablation for the Treatment of Clinically Localized Prostate Cancer: A Focal Therapy Society Best Practice Statement. Eur Urol. 2023 12; 84(6):547-560. Deivasigamani S, Kotamarti S, Rastinehad AR, Salas RS, de la Rosette JJMCH, Lepor H, Pinto P, Ahmed HU, Gill I, Klotz L, Taneja SS, Emberton M, Lawrentschuk N, Wysock J, Feller JF, Crouzet S, Kumar M P, Seguier D, Adams ES, Michael Z, Abreu A, Jack Tay K, Ward JF, Shinohara K, Katz AE, Villers A, Chin JL, Stricker PD, Baco E, Macek P, Ahmad AE, Chiu PKF, Crawford ED, Rogers CG, Futterer JJ, Rais-Bahrami S, Robertson CN, Hadaschik B, Marra G, Valerio M, Chong KT, Kasivisvanathan V, Tan WP, Lomas D, Walz J, Guimaraes GC, Mertziotis NI, Becher E, Finelli A, Kasraeian A, Lebastchi AH, Vora A, Rosen MA, Bakir B, Arcot R, Yee S, Netsch C, Meng X, de Reijke TM, Tan YG, Regusci S, Benjamin TGR, Olivares R, Noureldin M, Bianco FJ, Sivaraman A, Kim FJ, Given RW, Dason S, Sheetz TJ, Shoji S, Schulman A, Royce P, Shah TT, Scionti S, Salomon G, Laguna P, Tourinho-Barbosa R, Aminsharifi A, Cathelineau X, Gontero P, Stabile A, Grummet J, Ledbetter L, Graton M, Stephen Jones J, Polascik TJ, Focal Therapy Society. PMID: 37419773.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    6. Transperineal magnetic resonance imaging/transrectal ultrasonography fusion prostate biopsy under local anaesthesia: the 'double-freehand' technique. BJU Int. 2023 06; 131(6):770-774. Kaneko M, Medina LG, Lenon MSL, Sayegh AS, Lebastchi AH, Cacciamani GE, Aron M, Duddalwar V, Palmer SL, Gill IS, Abreu AL. PMID: 36755371.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    7. Patient-reported Satisfaction and Regret Following Focal Therapy for Prostate Cancer: A Prospective Multicenter Evaluation. Eur Urol Open Sci. 2023 Apr; 50:10-16. Ghoreifi A, Kaneko M, Peretsman S, Iwata A, Brooks J, Shakir A, Sugano D, Cai J, Cacciamani G, Park D, Lebastchi AH, Ukimura O, Bahn D, Gill I, Abreu AL. PMID: 37101771; PMCID: PMC10123415.
      View in: PubMed   Mentions: 5  
    8. Multiparametric ultrasound of prostate: role in prostate cancer diagnosis. Ther Adv Urol. 2022 Jan-Dec; 14:17562872221145625. Kaneko M, Lenon MSL, Storino Ramacciotti L, Medina LG, Sayegh AS, La Riva A, Perez LC, Ghoreifi A, Lizana M, Jadvar DS, Lebastchi AH, Cacciamani GE, Abreu AL. PMID: 36601020; PMCID: PMC9806443.
      View in: PubMed   Mentions: 7  
    9. An Assessment Tool to Provide Targeted Feedback to Robotic Surgical Trainees: Development and Validation of the End-To-End Assessment of Suturing Expertise (EASE). Urol Pract. 2022 Nov; 9(6):532-539. Haque TF, Hui A, You J, Ma R, Nguyen JH, Lei X, Cen S, Aron M, Collins JW, Djaladat H, Ghazi A, Yates KA, Abreu AL, Daneshmand S, Desai MM, Goh AC, Hu JC, Lebastchi AH, Lendvay TS, Porter J, Schuckman AK, Sotelo R, Sundaram CP, Gill IS, Hung AJ. PMID: 36844996; PMCID: PMC9948038.
      View in: PubMed   Mentions: 8     Fields:    
    10. Reply by Authors. Urol Pract. 2022 11; 9(6):541. Haque TF, Hui A, You J, Ma R, Nguyen JH, Lei X, Cen S, Aron M, Collins JW, Djaladat H, Ghazi A, Yates KA, Abreu AL, Daneshmand S, Desai MM, Goh AC, Hu JC, Lebastchi AH, Lendvay TS, Porter J, Schuckman AK, Sotelo R, Sundaram CP, Gill IS, Hung AJ. PMID: 37145829.
      View in: PubMed   Mentions:    Fields:    
    11. The Intraoperative Complications Assessment and Reporting with Universal Standards (ICARUS) Global Surgical Collaboration Project: Development of Criteria for Reporting Adverse Events During Surgical Procedures and Evaluating Their Impact on the Postoperative Course. Eur Urol Focus. 2022 Nov; 8(6):1847-1858. Cacciamani GE, Sholklapper T, Dell'Oglio P, Rocco B, Annino F, Antonelli A, Amenta M, Borghesi M, Bove P, Bozzini G, Cafarelli A, Celia A, Leonardo C, Ceruti C, Cindolo L, Crivellaro S, Dalpiaz O, Falabella R, Falsaperla M, Galfano A, Gallo F, Greco F, Minervini A, Parma P, Chiara Sighinolfi M, Pastore AL, Pini G, Porreca A, Pucci L, Sciorio C, Schiavina R, Umari P, Varca V, Veneziano D, Verze P, Volpe A, Zaramella S, Lebastchi A, Abreu A, Mitropoulos D, Shekhar Biyani C, Sotelo R, Desai M, Artibani W, Gill I, ICARUS Global Surgical Collaboration Working Group. PMID: 35177353.
      View in: PubMed   Mentions: 12     Fields:    
    12. Focal Therapy for Prostate Cancer: Getting Ready for Prime Time. Eur Urol. 2022 01; 81(1):34-36. Abreu AL, Kaneko M, Cacciamani GE, Lebastchi AH. PMID: 34740501.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    13. Comment on: "Fusion US/MRI prostate biopsy using a computer aided diagnostic (CAD) system". Minerva Urol Nephrol. 2021 10; 73(5):686-688. Sholklapper T, Checcucci E, Puliatti S, Taratkin M, Marenco J, Kowalewski KF, Gomez Rivas J, Rivero I, Lebastchi A, Abreu A, Cacciamani GE, Young Academic Urologists (YA U) Working Group in Uro-technology. PMID: 34847654.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    14. Focal Therapy for Low-Risk Prostate Cancer Opinion: No. J Endourol. 2021 Sep; 35(9):1284-1287. Sugano D, Abreu AL, Cacciamani GE, Gill IS, Lebastchi AH. PMID: 33849324.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    15. A Focus on Focal Therapy for Prostate Cancer. JAMA Surg. 2021 09 01; 156(9):881-882. Lebastchi AH, Gill IS, Abreu AL. PMID: 34319364.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    16. Future perspective of focal therapy for localized prostate cancer. Asian J Urol. 2021 Oct; 8(4):354-361. O'Connor LP, Ramedani S, Daneshvar M, George AK, Abreu AL, Cacciamani GE, Lebastchi AH. PMID: 34765443; PMCID: PMC8566361.
      View in: PubMed   Mentions: 2  
    17. MRI-guided focal laser ablation of prostate cancer: a prospective single-arm, single-center trial with 3 years of follow-up. Diagn Interv Radiol. 2021 May; 27(3):394-400. Mehralivand S, George AK, Hoang AN, Rais-Bahrami S, Rastinehad AR, Lebastchi AH, Ahdoot M, Siddiqui MM, Bloom J, Sidana A, Merino MJ, Choyke PL, Shih JH, Turkbey B, Wood BJ, Pinto PA. PMID: 34003127; PMCID: PMC8136525.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    18. Using Prostate Imaging-Reporting and Data System (PI-RADS) Scores to Select an Optimal Prostate Biopsy Method: A Secondary Analysis of the Trio Study. Eur Urol Oncol. 2022 04; 5(2):176-186. Ahdoot M, Lebastchi AH, Long L, Wilbur AR, Gomella PT, Mehralivand S, Daneshvar MA, Yerram NK, O'Connor LP, Wang AZ, Gurram S, Bloom J, Siddiqui MM, Linehan WM, Merino M, Choyke PL, Pinsky P, Parnes H, Shih JH, Turkbey B, Wood BJ, Pinto PA, Trio Study Group. PMID: 33846112; PMCID: PMC9346635.
      View in: PubMed   Mentions: 16     Fields:    Translation:Humans
    19. X-Capsular Incision for Tumor Enucleation (X-CITE)-Technique: A Method to Maximize Renal Parenchymal Preservation for Completely Endophytic Renal Tumors. Urology. 2021 08; 154:315-319. Lebastchi AH, Haynes B, Gurram S, Bratslavsky G, Metwalli AR, Linehan WM, Ball MW. PMID: 33831400; PMCID: PMC8820568.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    20. Comparative Effectiveness of Techniques in Targeted Prostate Biopsy. Cancers (Basel). 2021 Mar 22; 13(6). Sugano D, Kaneko M, Yip W, Lebastchi AH, Cacciamani GE, Abreu AL. PMID: 33810065; PMCID: PMC8004898.
      View in: PubMed   Mentions: 6  
    21. Techniques and Outcomes of MRI-TRUS Fusion Prostate Biopsy. Curr Urol Rep. 2021 Mar 22; 22(4):27. Kaneko M, Sugano D, Lebastchi AH, Duddalwar V, Nabhani J, Haiman C, Gill IS, Cacciamani GE, Abreu AL. PMID: 33748877; PMCID: PMC9827754.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    22. Risk of adverse pathology at prostatectomy in the era of MRI and targeted biopsies; rethinking active surveillance for intermediate risk prostate cancer patients. Urol Oncol. 2021 10; 39(10):729.e1-729.e6. Bloom JB, Daneshvar MA, Lebastchi AH, Ahdoot M, Gold SA, Hale G, Mehralivand S, Sanford T, Valera V, Wood BJ, Choyke PL, Merino MJ, Turkbey B, Parnes HL, Pinto PA. PMID: 33736975.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    23. Reply by Authors. J Urol. 2021 05; 205(5):1359-1360. Yerram NK, Long L, O'Connor LP, Wang AZ, Ahdoot M, Lebastchi AH, Gurram S, Zeng J, Chalfin H, Harmon SA, Mehralivand S, Merino MJ, Parnes HL, Choyke PL, Shih J, Wood BJ, Turkbey B, Pinto PA. PMID: 33705228.
      View in: PubMed   Mentions:    Fields:    
    24. Utilization of focal therapy for patients discontinuing active surveillance of prostate cancer: Recommendations of an international Delphi consensus. Urol Oncol. 2021 11; 39(11):781.e17-781.e24. Tan WP, Rastinehad AR, Klotz L, Carroll PR, Emberton M, Feller JF, George AK, Gill IS, Gupta RT, Katz AE, Lebastchi AH, Marks LS, Marra G, Pinto PA, Song DY, Sidana A, Ward JF, Sanchez-Salas R, Rosette J, Polascik TJ, Focal Therapy Group Authors. PMID: 33676851; PMCID: PMC8654321.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    25. 'Case of the Month' from the National Cancer Institute, Bethesda, MD, USA: investigating genetic aberrations in a patient with high-risk prostate cancer. BJU Int. 2021 02; 127(2):171-174. O'Connor LP, Lebastchi AH, Fasaye GA, Dikoglu E, Daneshvar MA, Ahdoot M, Merino MJ, Pinto PA. PMID: 33547722.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    26. Molecular biomarkers in the context of focal therapy for prostate cancer: recommendations of a Delphi Consensus from the Focal Therapy Society. Minerva Urol Nephrol. 2022 10; 74(5):581-589. Marra G, Laguna MP, Walz J, Pavlovich CP, Bianco F, Gregg J, Lebastchi AH, Lepor H, Macek P, Rais-Bahrami S, Robertson C, Rukstalis D, Salomon G, Ukimura O, Abreu AL, Barbe Y, Cathelineau X, Gandaglia G, George AK, Gomez Rivas J, Gupta RT, Lawrentschuk N, Kasivisvanathan V, Lomas D, Malavaud B, Margolis D, Matsuoka Y, Mehralivand S, Moschini M, Oderda M, Orabi H, Rastinehad AR, Remzi M, Schulman A, Shin T, Shiraishi T, Sidana A, Shoji S, Stabile A, Valerio M, Tammisetti VS, Phin Tan W, VAN DEN Bos W, Villers A, Willemse PP, DE LA Rosette J, Polascik T, Sanchez-Salas R, Focal Therapy Society. PMID: 33439577.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    27. Role of MRI for the detection of prostate cancer. World J Urol. 2021 Mar; 39(3):637-649. Wu RC, Lebastchi AH, Hadaschik BA, Emberton M, Moore C, Laguna P, Fütterer JJ, George AK. PMID: 33394091.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    28. Making a case "for" focal therapy of the prostate in intermediate risk prostate cancer: current perspective and ongoing trials. World J Urol. 2021 Mar; 39(3):729-739. Wang AZ, Lebastchi AH, O'Connor LP, Ahdoot M, Mehralivand S, Yerram N, Taneja SS, George AK, Sanchez-Salas R, Ward JF, Laguna P, de la Rosette J, Pinto PA. PMID: 33388878.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    29. Magnetic Resonance Imaging-Targeted and Systematic Biopsy for Detection of Grade Progression in Patients on Active Surveillance for Prostate Cancer. J Urol. 2021 05; 205(5):1352-1360. Yerram NK, Long L, O'Connor LP, Wang AZ, Ahdoot M, Lebastchi AH, Gurram S, Zeng J, Chalfin H, Harmon SA, Mehralivand S, Merino MJ, Parnes HL, Choyke PL, Shih J, Wood BJ, Turkbey B, Pinto PA. PMID: 33356479; PMCID: PMC9677228.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    30. Changes in Magnetic Resonance Imaging Using the Prostate Cancer Radiologic Estimation of Change in Sequential Evaluation Criteria to Detect Prostate Cancer Progression for Men on Active Surveillance. Eur Urol Oncol. 2021 04; 4(2):227-234. O'Connor LP, Wang AZ, Yerram NK, Long L, Ahdoot M, Lebastchi AH, Gurram S, Zeng J, Harmon SA, Mehralivand S, Merino MJ, Parnes HL, Choyke PL, Shih JH, Wood BJ, Turkbey B, Pinto PA. PMID: 33867045; PMCID: PMC9310665.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    31. Impact of the MyProstateScore (MPS) Test on the Clinical Decision to Undergo Prostate Biopsy: Results From a Contemporary Academic Practice. Urology. 2020 11; 145:204-210. Lebastchi AH, Russell CM, Niknafs YS, Eyrich NW, Chopra Z, Botbyl R, Kabeer R, Osawa T, Siddiqui J, Siddiqui R, Davenport MS, Mehra R, Tomlins SA, Kunju LP, Chinnaiyan AM, Wei JT, Tosoian JJ, Morgan TM. PMID: 32777370.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    32. PI-RADS® Category as a Predictor of Progression to Unfavorable Risk Prostate Cancer in Men on Active Surveillance. J Urol. 2020 12; 204(6):1229-1235. Wang AZ, O’Conno LP, Yerram NK, Long L, Zeng J, Mehralivand S, Harmon SA, Lebastchi AH, Ahdoot M, Gomella PT, Gurram S, Choyke PL, Merino MJ, Shih JH, Wood BJ, Turkbey B, Pinto PA. PMID: 32716685; PMCID: PMC8919058.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    33. Combined MRI-targeted Plus Systematic Confirmatory Biopsy Improves Risk Stratification for Patients Enrolling on Active Surveillance for Prostate Cancer. Urology. 2020 10; 144:164-170. O'Connor LP, Wang AZ, Yerram NK, Lebastchi AH, Ahdoot M, Gurram S, Zeng J, Mehralivand S, Harmon S, Merino MJ, Parnes HL, Choyke PL, Turkbey B, Wood BJ, Pinto PA. PMID: 32679272; PMCID: PMC8916164.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    34. Role of multiparametric prostate MRI in the management of prostate cancer. World J Urol. 2021 Mar; 39(3):651-659. O'Connor LP, Lebastchi AH, Horuz R, Rastinehad AR, Siddiqui MM, Grummet J, Kastner C, Ahmed HU, Pinto PA, Turkbey B. PMID: 32583039.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    35. Standardized Nomenclature and Surveillance Methodologies After Focal Therapy and Partial Gland Ablation for Localized Prostate Cancer: An International Multidisciplinary Consensus. Eur Urol. 2020 09; 78(3):371-378. Lebastchi AH, George AK, Polascik TJ, Coleman J, de la Rosette J, Turkbey B, Wood BJ, Gorin MA, Sidana A, Ghai S, Tay KJ, Ward JF, Sanchez-Salas R, Muller BG, Malavaud B, Mozer P, Crouzet S, Choyke PL, Ukimura O, Rastinehad AR, Pinto PA. PMID: 32532513; PMCID: PMC8966411.
      View in: PubMed   Mentions: 37     Fields:    Translation:HumansPHPublic Health
    36. Comparison of cross-sectional imaging techniques for the detection of prostate cancer lymph node metastasis: a critical review. Transl Androl Urol. 2020 Jun; 9(3):1415-1427. Lebastchi AH, Gupta N, DiBianco JM, Piert M, Davenport MS, Ahdoot MA, Gurram S, Bloom JB, Gomella PT, Mehralivand S, Turkbey B, Pinto PA, George AK. PMID: 32676426; PMCID: PMC7354341.
      View in: PubMed   Mentions: 6  
    37. MRI-Targeted, Systematic, and Combined Biopsy for Prostate Cancer Diagnosis. N Engl J Med. 2020 03 05; 382(10):917-928. Ahdoot M, Wilbur AR, Reese SE, Lebastchi AH, Mehralivand S, Gomella PT, Bloom J, Gurram S, Siddiqui M, Pinsky P, Parnes H, Linehan WM, Merino M, Choyke PL, Shih JH, Turkbey B, Wood BJ, Pinto PA. PMID: 32130814; PMCID: PMC7323919.
      View in: PubMed   Mentions: 282     Fields:    Translation:HumansCTClinical Trials
    38. Salvage robotic transmesenteric off-clamp partial nephrectomy after multiple prior open kidney surgeries. Urol Case Rep. 2020 May; 30:101135. O'Connor LP, Lebastchi AH, Brems J, Wang AZ, Linehan WM, Ball MW. PMID: 32140418; PMCID: PMC7044506.
      View in: PubMed   Mentions: 1  
    39. Focal therapy for prostate cancer: recent advances and future directions. Clin Adv Hematol Oncol. 2020 Feb; 18(2):116-125. Wang A, O'Connor LP, Yerram NK, Nandanan N, Ahdoot M, Lebastchi AH, Gurram S, Chalfin H, Pinto PA. PMID: 32558805.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    40. Use of multiparametric magnetic resonance imaging and fusion-guided biopsies to properly select and follow African-American men on active surveillance. BJU Int. 2019 11; 124(5):768-774. Bloom JB, Lebastchi AH, Gold SA, Hale GR, Sanford T, Mehralivand S, Ahdoot M, Rayn KN, Czarniecki M, Smith C, Valera V, Wood BJ, Merino MJ, Choyke PL, Parnes HL, Turkbey B, Pinto PA. PMID: 31141307; PMCID: PMC8288555.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    41. Contemporary treatments in prostate cancer focal therapy. Curr Opin Oncol. 2019 05; 31(3):200-206. Ahdoot M, Lebastchi AH, Turkbey B, Wood B, Pinto PA. PMID: 30865133; PMCID: PMC6465079.
      View in: PubMed   Mentions: 43     Fields:    Translation:Humans
    42. The role of multiparametric MRI in biopsy-naive prostate cancer. Nat Rev Urol. 2019 May; 16(5):276-277. Lebastchi AH, Pinto PA. PMID: 30914803.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    43. Super active surveillance for low-risk prostate cancer | Opinion: No. Int Braz J Urol. 2019 Mar-Apr; 45(2):215-219. Ghodoussipour S, Lebastchi AH, Bloom JB, Pinto PA, Berger A. PMID: 31021585; PMCID: PMC6541137.
      View in: PubMed   Mentions:    Fields:    Translation:HumansPHPublic Health
    44. Multi-institutional Survival Analysis of Incidental Pathologic T3a Upstaging in Clinical T1 Renal Cell Carcinoma Following Partial Nephrectomy. Urology. 2018 Jul; 117:95-100. Russell CM, Lebastchi AH, Chipollini J, Niemann A, Mehra R, Morgan TM, Miller DC, Palapattu GS, Hafez KS, Sexton WJ, Spiess PE, Weizer AZ. PMID: 29678662.
      View in: PubMed   Mentions: 20     Fields:    Translation:Humans
    45. Author Reply. Urology. 2018 05; 115:58. Lebastchi AH, Ambani SN. PMID: 29602564.
      View in: PubMed   Mentions:    Fields:    
    46. The Urology Applicant: An Analysis of Contemporary Urology Residency Candidates. Urology. 2018 05; 115:51-58. Lebastchi AH, Khouri RK, McLaren ID, Faerber GJ, Kraft KH, Hafez KS, Dauw CA, Bird VG, Stringer TF, Singla AK, Sorensen MD, Wessells H, Ambani SN. PMID: 29408686.
      View in: PubMed   Mentions: 12     Fields:    Translation:Humans
    47. Detailed pathologic analysis on the co-occurrence of non-seminomatous germ cell tumor subtypes in matched orchiectomy and retroperitoneal lymph node dissections. Med Oncol. 2018 Jan 31; 35(3):21. Spratt DE, Suresh K, Osawa T, Schipper M, Jackson WC, Abugharib A, Lebastchi A, Smith D, Montgomery JS, Palapattu GS, Priya Kunju L, Wu A, Lew M, Tomlins SA, Chinnaiyan AM, Weizer AZ, Hafez KS, Kaffenberger SD, Udager A, Mehra R. PMID: 29387987.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    48. Using Imaging to Predict Treatment Response in Genitourinary Malignancies. Eur Urol Focus. 2018 12; 4(6):804-817. Lebastchi AH, Watson MJ, Russell CM, George AK, Weizer AZ, Turkbey B. PMID: 28918178.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    49. Robotic-assisted Thoracoscopic Transdiaphragmatic Adrenalectomy (RATTA) for Metastatic Renal Cell Carcinoma. Urology. 2017 Jul; 105:9-12. Russell CM, Salami SS, Lebastchi AH, Lagisetty KH, Mehra R, Hafez KS, Reddy RM, Weizer AZ. PMID: 28982516.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    50. The Role of Transurethral Resection in Trimodal Therapy for Muscle-Invasive Bladder Cancer. Bladder Cancer. 2016 Oct 27; 2(4):381-394. Russell CM, Lebastchi AH, Borza T, Spratt DE, Morgan TM. PMID: 28035319; PMCID: PMC5181666.
      View in: PubMed   Mentions: 7  
    51. Combining disparate surgical residencies into one: lessons learned. J Surg Res. 2015 Oct; 198(2):289-93. Tackett JJ, Longo WE, Lebastchi AH, Nadzam GS, Yoo PS. PMID: 25986211.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    52. Real-Time Super Selective Venous Sampling in Remedial Parathyroid Surgery. J Am Coll Surg. 2015 Jun; 220(6):994-1000. Lebastchi AH, Aruny JE, Donovan PI, Quinn CE, Callender GG, Carling T, Udelsman R. PMID: 25868412.
      View in: PubMed   Mentions: 12     Fields:    Translation:Humans
    53. Peri-operative considerations in the patient with primary immune deficiency: a review. Surg Infect (Larchmt). 2014 Dec; 15(6):672-8. Pagovich OE, Lebastchi AH, Romberg N. PMID: 25317569.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansPHPublic Health
    54. Paradigm shift in the surgical management of multigland parathyroid hyperplasia: an individualized approach. JAMA Surg. 2014 Nov; 149(11):1133-7. Lebastchi AH, Donovan PI, Udelsman R. PMID: 25188005.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    55. Modern experience with aggressive parathyroid tumors in a high-volume New England referral center. J Am Coll Surg. 2015 Jun; 220(6):1054-62. Quinn CE, Healy J, Lebastchi AH, Brown TC, Stein JE, Prasad ML, Callender GG, Carling T, Udelsman R. PMID: 25488353.
      View in: PubMed   Mentions: 30     Fields:    Translation:Humans
    56. Thyroid cancer. Curr Probl Cancer. 2014 Mar-Apr; 38(2):48-74. Lebastchi AH, Callender GG. PMID: 24951026.
      View in: PubMed   Mentions: 20     Fields:    Translation:Humans
    57. First nationwide survey of US integrated 6-year cardiothoracic surgical residency program directors. J Thorac Cardiovasc Surg. 2014 Aug; 148(2):408-15.e1. Lebastchi AH, Tackett JJ, Argenziano M, Calhoon JH, Gasparri MG, Halkos ME, Hicks GL, Iannettoni MD, Ikonomidis JS, McCarthy PM, Starnes SL, Tong BC, Yuh DD. PMID: 24820188; PMCID: PMC4336151.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    58. Nationwide survey of US integrated 6-year cardiothoracic surgical residents. J Thorac Cardiovasc Surg. 2014 Aug; 148(2):401-7. Lebastchi AH, Yuh DD. PMID: 24746993.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    59. Appendiceal endometriosis in a pregnant woman presenting with acute perforated appendicitis. J Surg Case Rep. 2013 Dec 16; 2013(12). Lebastchi AH, Prieto PA, Chen C, Lui FY. PMID: 24968435; PMCID: PMC3888003.
      View in: PubMed   Mentions: 4  
    60. TNF, acting through inducibly expressed TNFR2, drives activation and cell cycle entry of c-Kit+ cardiac stem cells in ischemic heart disease. Stem Cells. 2013 Sep; 31(9):1881-92. Al-Lamki RS, Lu W, Wang J, Yang J, Sargeant TJ, Wells R, Suo C, Wright P, Goddard M, Huang Q, Lebastchi AH, Tellides G, Huang Y, Min W, Pober JS, Bradley JR. PMID: 23712715; PMCID: PMC3795817.
      View in: PubMed   Mentions: 13     Fields:    Translation:HumansAnimalsCells
    61. Immune therapy and β-cell death in type 1 diabetes. Diabetes. 2013 May; 62(5):1676-80. Lebastchi J, Deng S, Lebastchi AH, Beshar I, Gitelman S, Willi S, Gottlieb P, Akirav EM, Bluestone JA, Herold KC. PMID: 23423576; PMCID: PMC3636605.
      View in: PubMed   Mentions: 47     Fields:    Translation:HumansCells
    62. The effects of vitamin D repletion on endothelial function and inflammation in patients with coronary artery disease. Vasc Med. 2012 Dec; 17(6):394-404. Sokol SI, Srinivas V, Crandall JP, Kim M, Tellides G, Lebastchi AH, Lebastchi A, Yu Y, Gupta AK, Alderman MH. PMID: 23184900.
      View in: PubMed   Mentions: 46     Fields:    Translation:Humans
    63. Adrenocortical Carcinoma: Current Therapeutic State-of-the-Art. J Oncol. 2012; 2012:234726. Lebastchi AH, Kunstman JW, Carling T. PMID: 23125857; PMCID: PMC3483813.
      View in: PubMed   Mentions: 21  
    64. Neutralizing IL-6 reduces human arterial allograft rejection by allowing emergence of CD161+ CD4+ regulatory T cells. J Immunol. 2011 Dec 15; 187(12):6268-80. Fogal B, Yi T, Wang C, Rao DA, Lebastchi A, Kulkarni S, Tellides G, Pober JS. PMID: 22084439; PMCID: PMC3237826.
      View in: PubMed   Mentions: 23     Fields:    Translation:HumansAnimalsCells
    65. Activation of human vascular cells decreases their expression of transforming growth factor-beta. Atherosclerosis. 2011 Dec; 219(2):417-24. Lebastchi AH, Qin L, Khan SF, Zhou J, Geirsson A, Kim RW, Li W, Tellides G. PMID: 21862019; PMCID: PMC3226933.
      View in: PubMed   Mentions: 14     Fields:    Translation:HumansCells
    66. Transforming growth factor beta expression by human vascular cells inhibits interferon gamma production and arterial media injury by alloreactive memory T cells. Am J Transplant. 2011 Nov; 11(11):2332-41. Lebastchi AH, Khan SF, Qin L, Li W, Zhou J, Hibino N, Yi T, Rao DA, Pober JS, Tellides G. PMID: 21812925; PMCID: PMC3203343.
      View in: PubMed   Mentions: 14     Fields:    Translation:HumansAnimalsCells
    67. IFN-gamma primes intact human coronary arteries and cultured coronary smooth muscle cells to double-stranded RNA- and self-RNA-induced inflammatory responses by upregulating TLR3 and melanoma differentiation-associated gene 5. J Immunol. 2010 Jul 15; 185(2):1283-94. Ahmad U, Ali R, Lebastchi AH, Qin L, Lo SF, Yakimov AO, Khan SF, Choy JC, Geirsson A, Pober JS, Tellides G. PMID: 20562257; PMCID: PMC2902797.
      View in: PubMed   Mentions: 12     Fields:    Translation:HumansAnimalsCells
    Amir's Networks
    Concepts (235)
    Derived automatically from this person's publications.
    Explore
    _
    Co-Authors (19)
    People in Profiles who have published with this person.
    Explore
    _
    Similar People (60)
    People who share similar concepts with this person.
    Explore
    _
    Same Department
    Search Department
    _

    NIH Funding Acknowledgment: Important - All publications resulting from the utilization of SC CTSI resources are required to credit the SC CTSI grant by including the NIH funding acknowledgment and must comply with the NIH Public Access Policy.

    This site is running Profiles RNS version UCSF-v3.1.0-6-g69de2244 on PROFILES-PWEB04. We use cookies to operate our website. We also use cookies to analyze our site’s performance and improve your experience on our site. For more information about how we use cookies, please see our Website Terms of Use.